A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

NCT06057935 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Malignant Peritoneal Mesothelioma
Peritoneal Mesothelioma
Mesothelioma
Mesothelioma, Malignant
Malignant Mesothelioma

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Carboplatin

Sponsor

Memorial Sloan Kettering Cancer Center